“The medication changed my life but the side effects are hard”: navigating the first 3 months

The first day on medication, Priya listened to an entire podcast without rewinding. She read a chapter of a book. She finished her tax return in one sitting. After 36 years of a brain that would not cooperate, something had shifted. Two weeks later, she could not eat, her heart raced every afternoon, and she lay awake until 2am most nights. “The medication changed my life,” she told her GP, “but I am not sure I can keep doing this.”

This is a composite scenario based on common patient experiences. It does not represent any individual patient.

What you will find in this article

• The first week: why everything feels different
• Weeks 2 to 4: the settling phase
• Common side effects and how to manage them
• Dose adjustments: how your GP fine-tunes treatment
• GP conversations that help vs the ones that do not
• What stable looks like after 3 months

The first week: why everything feels different

Priya started on 20mg lisdexamfetamine (Vyvanse), the lowest available dose. The first day’s experience is one that many adults with ADHD describe in nearly identical terms: “I could think clearly for the first time in my life.”

This initial response is real, not placebo. Stimulant medications increase dopamine and noradrenaline availability in the prefrontal cortex within 1 to 2 hours of the first dose. For a brain that has been dopamine-deficient since birth, the effect is immediate and noticeable.

Clinicians sometimes call this the “honeymoon phase.” The clarity feels dramatic because the contrast with baseline is so large. Patients report being able to follow conversations, finish tasks they have been avoiding for months, and sit through a film without checking their phone. Some describe a feeling of calm they have never experienced.

The honeymoon fades, and this is normal. After 1 to 2 weeks, the brain adjusts to the new dopamine baseline. The medication is still working, but the dramatic contrast disappears. What remains is a more subtle improvement in function that patients sometimes mistake for the medication “stopping working.” It has not. The novelty has worn off, but the therapeutic effect continues.

Weeks 2 to 4: the settling phase

For Priya, weeks 2 to 4 were the hardest. The cognitive benefits were still present but less pronounced. The side effects were at their peak. She felt caught between “this is helping” and “I do not feel right.”

During this phase, the body is recalibrating. Appetite, sleep, cardiovascular response, and mood regulation all adjust to the presence of a stimulant. The Australian ADHD clinical practice guideline recommends that GPs see patients every 2 to 4 weeks during this period, specifically because side effects are most prominent and most manageable with timely intervention.

Priya’s settling phase included:

• Days 7 to 14: appetite suppression peaked. She skipped lunch most days without realising it, then felt lightheaded by 3pm.
• Days 10 to 21: sleep onset delay. The medication’s effect lasted longer than expected, and she could not fall asleep before midnight.
• Days 14 to 28: a mild afternoon “crash” as the medication wore off. Irritability and fatigue appeared around 4 to 5pm daily.
• Throughout: slightly elevated resting heart rate (up by 8 to 10 beats per minute from baseline), which her GP monitored.

All of these side effects fall within the expected range for stimulant titration. Approximately 80% of adults starting stimulant medication experience appetite changes, and 75 to 80% report some sleep disruption. Both typically improve within 4 to 6 weeks as the body adapts.

Common side effects and how to manage them

Most stimulant side effects are dose-dependent and manageable. The key is having a GP who knows what to expect, communicates the timeline, and adjusts proactively rather than reactively.

Appetite suppression. The most common side effect. Stimulants suppress hunger signals, particularly between 10am and 4pm when the medication is at peak concentration. Practical strategies: eat a solid breakfast before the medication takes effect (within 30 minutes of waking), set a lunch alarm, and eat a larger dinner. Priya’s GP suggested high-calorie, low-volume snacks (nuts, cheese, smoothies) during the day when eating a full meal felt impossible.

Sleep disruption. Stimulants taken too late in the day interfere with sleep onset. For lisdexamfetamine (Vyvanse), the general rule is to take it before 8am so the active metabolite clears by bedtime. Priya’s GP adjusted her dosing time from 8:30am to 7am, which resolved most of her sleep issues within a week.

Elevated heart rate. Stimulants increase heart rate by an average of 5 to 10 beats per minute and blood pressure by 2 to 4 mmHg. This is clinically insignificant for most adults with normal cardiovascular health. The Australian clinical guideline recommends baseline blood pressure and heart rate measurement before starting medication, with monitoring at each dose change. Priya’s GP checked her vitals at every review for the first 3 months.

Afternoon crash. As the medication wears off, some adults experience a rebound effect: a temporary worsening of ADHD symptoms, irritability, or fatigue. This is the brain’s response to the rapid drop in dopamine stimulation. Strategies include dose timing adjustments, switching to a different release profile, or adding a small afternoon booster dose. Priya’s crash resolved when her GP increased her dose from 20mg to 30mg, which extended the medication’s effective window.

Emotional blunting. Some adults report feeling “flat” or “robotic” on stimulants, losing the emotional range they are used to. This is a sign the dose is too high or the medication is not the right fit. Priya did not experience this, but her GP had flagged it as something to watch for. If emotional blunting occurs, the GP reduces the dose or trials a different stimulant class (switching from amphetamine-based to methylphenidate-based, or vice versa).

Dose adjustments: how your GP fine-tunes treatment

ADHD medication rarely works perfectly at the first dose. The clinical guideline recommends a “start low, go slow” titration approach: begin at the lowest dose, increase gradually at 2 to 4 week intervals, and stop when symptoms improve and side effects are tolerable.

Priya’s titration timeline:

1. Weeks 1 to 2: 20mg lisdexamfetamine. Noticeable benefit for focus and task initiation. Significant appetite suppression and sleep disruption.
2. Week 2 review: GP adjusted dosing time to 7am. Added breakfast-before-medication rule. Scheduled next review for week 4.
3. Weeks 3 to 4: Sleep improved. Appetite still reduced but manageable with scheduled eating. Afternoon crash emerging around 4pm.
4. Week 4 review: GP increased dose to 30mg based on symptom reports and tolerability. Reviewed blood pressure and heart rate (both within normal range).
5. Weeks 5 to 8: 30mg provided longer symptom coverage (effective until approximately 5:30pm). Appetite stabilised. Sleep pattern normalised. No emotional blunting.
6. Week 8 review: GP confirmed stable response. Moved to monthly reviews. Discussed long-term monitoring plan.
7. Month 3: Stable. Consistent benefit without significant side effects. Priya described feeling “like myself, but functioning.”

Stimulants have a response rate of approximately 90% across the two main classes (amphetamine-based and methylphenidate-based). If the first medication does not work or produces intolerable side effects, the GP trials the other class. Between the two, most adults find an effective option. For the small percentage who do not respond to either stimulant class, non-stimulant options like atomoxetine or guanfacine are available.

GP conversations that help vs the ones that do not

Priya’s experience was shaped by having a GP who specialised in ADHD management. Not all medication journeys go this smoothly. The difference often comes down to the quality of the clinical conversation.

Conversations that help:

• “These side effects are expected in the first 2 weeks and usually settle. Here is what to do in the meantime.” (Sets expectations and provides strategies.)
• “Describe what the medication does between 9am and 5pm, hour by hour.” (Helps the GP understand the medication’s effective window and identify when to adjust.)
• “How is your appetite? When did you last eat a full meal?” (Proactive screening for the most common side effect.)
• “The honeymoon phase has passed, but the medication is still working. The improvement you see now is the real baseline.” (Prevents premature dose escalation.)

Conversations that do not help:

• “If you are having side effects, we should stop the medication.” (Side effects in the first 2 weeks are expected, not necessarily a reason to abandon treatment unless side effects are severe.)

The specialist GP pathway in Queensland exists specifically because ADHD medication management requires clinical expertise and ongoing relationship. A GP who understands titration, side effect timelines, and the difference between a honeymoon ending and medication failure is the difference between a successful treatment journey and an abandoned one.

What stable looks like after 3 months

“Stable” does not mean perfect. At the 3-month mark, Priya described her experience like this: “The medication does not make me a different person. It makes me the person I always was, but without the fog. I still lose my keys sometimes. I still get distracted. But I can catch myself and come back to what I was doing. Before, I could not.”

Stable ADHD medication after 3 months typically looks like:

• Consistent improvement in task initiation, sustained attention, and working memory
• Side effects either resolved or manageable (mild appetite suppression is common long-term but not disruptive)
• Emotional regulation improved but not flattened
• Sleep pattern normalised (with appropriate dosing time)
• The patient describes feeling “like myself” rather than “medicated”
• Functional gains visible in work, relationships, or daily life management

After stabilisation, ongoing monitoring shifts to every 3 to 6 months. The GP checks blood pressure, heart rate, weight, and medication effectiveness. Annual reviews include a broader assessment of ADHD symptom management and any emerging comorbidities.

Frequently asked questions

The first 3 months on ADHD medication are the hardest part of the treatment journey. Side effects are real, the honeymoon fades, and doubts creep in. With a specialist GP who understands the titration process and provides regular reviews, most adults find a stable, effective treatment within that timeframe. If you are considering ADHD assessment and treatment, book an assessment or learn about the GP assessment pathway.